SERA
Sera Prognostics IncNASDAQHEALTHCAREMEDICAL DEVICES
Key Statistics
Market Cap
$81.06M
P/E Ratio
—
EPS
$-0.64
Beta
0.93
52W High
$4.09
52W Low
$1.37
50-Day MA
$1.98
200-Day MA
$2.73
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Sera Prognostics Inc
Sera Prognostics Inc. is a pioneering company in maternal-fetal health, dedicated to developing cutting-edge diagnostic solutions that enhance pregnancy outcomes. Its flagship product, the PreTRM test, employs a proprietary biomarker platform to provide precise assessments of preterm birth risk, enabling healthcare providers to implement timely interventions. With a strong focus on advancing prenatal diagnostics, Sera is strategically positioned for growth within this vital healthcare market. The company's innovative approach not only meets pressing clinical demands but also promises sustainable value creation for its investors.
Fundamentals
| Revenue (TTM) | 57,000 |
| Gross Profit (TTM) | -109,000 |
| EBITDA | $-35.81M |
| Operating Margin | -66857.00% |
| Return on Equity | -39.60% |
| Return on Assets | -21.60% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $1.94 |
| Price-to-Book | 1.15 |
| Price-to-Sales (TTM) | 1422.08 |
| EV/Revenue | 579.47 |
| EV/EBITDA | -0.61 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -63.20% |
| Shares Outstanding | $38.19M |
| Float | $27.58M |
| % Insiders | 11.68% |
| % Institutions | 63.06% |
Historical Volatility
HV 10-Day
113.96%
HV 20-Day
84.48%
HV 30-Day
79.30%
HV 60-Day
80.73%
HV Rank
—
Volatility is currently expanding
Analyst Ratings
Consensus ($5.00 target)
3
BuyMore HEALTHCARE Stocks
Data last updated: 5/25/2026